aTyr Pharma (LIFE) Tops Q4 EPS by 22c

aTyr Pharma (NASDAQ: LIFE) reported Q4 EPS of ($0.26), $0.22 better than the analyst estimate of ($0.48). Revenue for the quarter came in at $10.4 thousand versus the consensus estimate of $416.67 thousand.

For earnings history and earnings-related data on aTyr Pharma (LIFE) click here.

You May Also Be Interested In

• Oracle (ORCL) Tops Q1 EPS by 19c, Beats on Revenue; Beats on Cloud Revenue, Offers Q3 EPS Guidance
• B.Riley Starts Neuronetics (STIM) at Buy
• Oracle raises full year profit guidance, stock rises after hours